Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Original NDA and Original BLA Approvals
August 1941

This report includes NDAs [including NDAs for new molecular entities (NMEs)] and BLAs (including new biological products) approved for the first time during the selected month. Original BLA/NDA approvals by CBER are not included in Drugs@FDA. This report does not include approved NDA or BLA supplements, approved ANDAs, or tentatively approved ANDAs/NDAs.

Click on the Drug Name and Application Number to see information about the drug (for example, regulatory history, labeling, reviews by FDA staff).

This report was produced on November 28, 2020.

Approval Date Drug Name Active Ingredients Submission Classification * Review Priority ** Company
08/11/1941 SULFADIAZINE
NDA #004054
SULFADIAZINE LEDERLE
08/11/1941 SULFADIAZINE SODIUM
NDA #004054
SULFADIAZINE SODIUM LEDERLE
08/26/1941 SULFADIAZINE
NDA #004122
SULFADIAZINE Type 5 - New Formulation or New Manufacturer Standard LILLY

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English